Modeling how pediatric anti-infective drugs behave in kids
Part of Infections clinical trials.
This trial studies how certain anti-infective medicines (for bacterial and fungal infections) move through the body in children. The goal is to use that information to improve how these medicines are dosed and used safely in pediatric care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A parent/guardian (or you, if allowed) can sign informed consent
- Your child has a bacterial and/or fungal infection where a listed anti-infective drug is clinically appropriate
- There is no known proven allergy to the anti-infective medicines being used
- You have written consent on file
- Your child is not on combination therapy with at least two antibacterial drugs and/or at least two antifungal drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial measures how anti-infective medicines move through a child’s body while they are in the hospital or during follow-up. The goal is to better understand dosing and drug exposure in critically ill children.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
This study looks at how caspofungin works in children who are very sick and in the pediatric intensive care unit. It helps doctors better choose dosing to keep the medicine at the right level.
This trial tests a personalized dosing approach for certain antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam, and meropenem) in hospitalized children with serious infections. The goal is to adjust the dose based on blood tests to make sure each child gets the right amount of medicine.
This study looks at how common TB medicines are absorbed, used, and cleared in children who are already taking treatment for tuberculosis. It may help doctors choose safer and more effective doses for children.
This trial studies how to give the right dose of common antibiotics to children on ECMO (a heart-lung bypass machine). The goal is to help doctors choose the best dose to fight infections while keeping the child safe.
Hear when a new Population Modeling of Anti-infective Drugs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.